Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6115418 | Diagnostic Microbiology and Infectious Disease | 2016 | 4 Pages |
Abstract
We evaluated the feasibility and efficacy of a commercially available methicillin-resistant Staphylococcus aureus (MRSA)-selective agar, chromID⢠MRSA, to detect group B streptococci with reduced penicillin susceptibility (PRGBS) in this study. The results showed 72.4% (21/29) sensitivity and 98.4% (60/61) specificity to detect PRGBS using this method.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Shinako Fukigai, Makiko Morimoto, Kouji Kimura, Yo Doyama, Akira Miyazaki, Chitose Kamiya, Hirotsugu Banno, Eriko Morishima, Tomohiro Onoda, Noriyuki Nagano, Wanchun Jin, Jun-ichi Wachino, Keiko Yamada, Yoshichika Arakawa,